This study sought to address the gaps in knowledge by investigating the effects of exposing progesterone receptor (PR)-positive human breast cancer cells to different progestins on the transcriptional expression of primiR-190 and primiR-199a1. The gene discussed is PGR; the disease is breast cancer.